Clinical issues with uremia;Klinische probleme der urämie

Internist

Volumn 53, Issue 7, 2012, Pages 817-822

  Girndt, M ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cardiovascular diseases; Chronic; Dialysis; Inflammation; Kidney failure; Uremia

Indexed keywords

PROTEIN; TOXIN;

ACUTE DISEASE; ANEMIA; ARTICLE; BONE METABOLISM; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; COMA; DIALYSIS; ENERGY METABOLISM; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNE DEFICIENCY; INTOXICATION; KIDNEY CLEARANCE; KIDNEY TRANSPLANTATION; MALNUTRITION; MOLECULAR WEIGHT; NUCLEIC ACID METABOLISM; PERICARDITIS; PLEURISY; POLYNEUROPATHY; RENAL REPLACEMENT THERAPY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UREMIA; URINARY EXCRETION;

HUMANS; KIDNEY FAILURE, CHRONIC; RENAL REPLACEMENT THERAPY; UREMIA;

EID: 84864490061     PISSN: 00209554     EISSN: 14321289     Source Type: Journal    
DOI: 10.1007/s00108-011-3013-2     Document Type: Article

References (23)

1. Aguilera A et al (2004) Eating behavior disorders in uremia: a question of balance in appetite regulation. Semin Dial 17:44-52 (Pubitemid 38376691)
2. Auffray C et al (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317:666-670 (Pubitemid 47229966)
3. Chiang CK, Tanaka T, Inagi R et al (2011) Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner. Lab Invest 91:1564-1571
4. Del Vecchio L, Locatelli F, Carini M (2011) What we know about oxidative stress in patients with chronic kidney disease on dialysis - clinical effects, potential treatment, and prevention. Semin Dial 24:56-64
5. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:112-119
6. Girndt M et al (2002) Anti-inflammatory interleukin- 10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62:949-955 (Pubitemid 35316724)
7. Girndt M, Sester M, Sester U et al (2001) Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int 59:1382-1389 (Pubitemid 32281226)
8. Girndt M, Sester U, Kaul H, Köhler H (1998) Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single cell level. J Am Soc Nephrol 9:1689-1696
9. Haaber AB, Eidemak I, Jensen T et al (1995) Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure. J Am Soc Nephrol 5:1581-1584
10. Kielstein JT et al (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10:594-600 (Pubitemid 29117641)
11. Locatelli F et al (2009) Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 20:645-654
12. Longenecker JC et al (2002) Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE study. J Am Soc Nephrol 13:1918-1927 (Pubitemid 34700618)
13. Mak RH, Cheung W, Cone RD, Marks DL (2006) Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol 2:527-534 (Pubitemid 44325964)
14. Nangaku M, Eckardt KU (2006) Pathogenesis of renal anemia. Semin Nephrol 26:261-268 (Pubitemid 44722454)
15. Pupim LB, Caglar K, Hakim RM et al (2004) Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 66:2054-2060
16. Ridker PM, Cushman M, Stampfer MJ et al (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979 (Pubitemid 27152782)
17. Rocco MV et al (2011) The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 80:1080-1091
18. US Renal Data System (2010) USRDS 2009 Annual Data Report: atlas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda/MD
19. Ulrich C, Heine GH, Seibert E et al (2010) Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease. Nephrol Dial Transplant 25:2265-2272
20. Ulrich C, Seibert E, Heine GH et al (2011) Monocyte angiotensin converting enzyme expression may be associated with atherosclerosis rather than arteriosclerosis in hemodialysis patients. Clin J Am Soc Nephrol 6:505-511
21. Vanholder R, Baurmeister U, Brunet P et al (2008) A bench to bedside view of uremic toxins. J Am Soc Nephrol 19:863-870
22. Wahl P, Wolf M (2012) FGF23 in chronic kidney disease. Adv Exp Med Biol 728:107-125
23. Zimmermann J, Herrlinger S, Pruy A et al (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658 (Pubitemid 29082891)